Volume 24, Issue 2 - Risk Management

Using social media as the patient's voice in the benefit-risk assessment of drugs: Are we ready?

Authors: Massoud Toussi, Lisa Chamberlain James, Sir Alasdair Breckenridge

Abstract

Download the full article

References

1. Safety of medicines – A guide to detecting and reporting adverse drug reactions – why health professionals need to take action. World Health Organization [2002; cited 2015 Jan 28]. Available from: http://apps.who.int/medicinedocs/en/d/Jh2992e/#Jh2992e
2. The safety of medicines in public health programmes: Pharmacovigilance an essential tool. World Health Organization [2006; cited 2015 Jan 28]. Available from: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/Pharmacovigilance_B.pdf?ua=1
3. FDA adverse event reporting systems (FEARS). US Food and Drug Administration (FDA) [cited 2015 Jan 28]. Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/
4. MHRA adverse drug reactions. Medicines and Healthcare Products Regulatory Agency [cited 2015 Jan 28]. Available from: https://www.gov.uk/the-yellow-card-scheme-guidance-for-healthcare-professionals
5. Wikibon Blog. The big list of big data infographics [2012 July 24; cited 2015 Feb 09]. Available from: http://wikibon.org/blog/big-data-infographics
6. IACP Center for Social Media. Fun facts. International Association of Chiefs of Police [2010–2015; cited 2015 Feb 09]. Available from: http://www.iacpsocialmedia.org/Resources/FunFacts.aspx
7. Wikibon Blog. A comprehensive list of big data statistics [2012 Aug 1; cited 2015 Feb 09]. Available from: http://wikibon.org/blog/big-data-statistics/
8. Freifeld CC, Brownstein JS, Menone CM, Bao W, Filice R, Kass-Hout T, et al. Digital drug safety surveillance: Monitoring pharmaceutical products in twitter. Drug Saf. 2014;37(5):343–50.
9. McGregor F, Somner JE, Bourne RR, Munn-Giddings C, Shah P, Cross V. Social media use by patients with glaucoma: what can we learn? Ophthalmic Physiol Opt. 2014;34(1):46–52.
10. Banerjee AK, Ingate S. Web-based patient-reported outcomes in drug safety and risk management: Challenges and opportunities? Drug Saf. 2012;35(6):437–46.
11. Wu H, Fang H, Stanhope SJ. Exploiting online discussions to discover unrecognized drug side effects. Methods Inf Med. 2013;52(2):152–9.
12. Mao JJ, Chung A, Benton A, Hill S, Ungar L, Leonard CE, et al. Online discussion of drug side effects and discontinuation among breast cancer survivors. Pharmacoepidemiol Drug Saf. 2013;22(3):256–62.
13. Vaughan Sarrazin MS, Cram P, Mazur A, Ward M, Reisinger HS. Patient perspectives of dabigatran: Analysis of online discussion forums. Patient. 2014;7(1):47–54.
14. Abou Taam M, Rossard C, Cantaloube L, Bouscaren N, Roche G, Pochard L, et al. Analysis of patients’ narratives posted on social media websites on benfluorex's (Mediator®) withdrawal in France. J Clin Pharm Ther. 2014;39(1):53–5.